Fig. 5From: Recent trends in preparation and biomedical applications of iron oxide nanoparticlesSchematic illustration of synthesis and applications of iron oxide nanoparticles in vitro. SPIO@PSS/CPT-11/HSA-anti-CD133 nanoparticles (A, [88]). USPIO@MIL-100(Fe) nano-objects (B, [109]). CPT-11: Irinotecan. HSA: Human serum albumin. PSS; Poly (sodium styrene sulfonate). SPIO: Superparamagnetic iron oxideBack to article page